Ontology highlight
ABSTRACT: Purpose
Most professional guidelines recommend against genetic screening for adult-onset only (AO) conditions until adulthood, yet others argue that there may be benefit to disclosing such results. We explored parents' decision-making on this issue in the BabySeq Project, a clinical trial of newborn genomic sequencing.Methods
We conducted interviews with parents (N = 24) who were given the option to receive actionable AO results for their children. Interviews explored parents' motivations to receive and reasons to decline AO genetic disease risk information, their decision-making process, and their suggestions for supporting parents in making this decision.Results
Parents noted several motivations to receive and reasons to decline AO results. Most commonly, parents cited early intervention/surveillance (n = 11), implications for family health (n = 7), and the ability to prepare (n = 6) as motivations to receive these results. The most common reasons to decline were protection of the child's future autonomy (n = 4), negative effect on parenting (n = 3), and anxiety about future disease (n = 3). Parents identified a number of ways to support parents in making this decision.Conclusion
Results show considerations to better support parental decision-making that aligns with their values when offering AO genetic information because it is more commonly integrated into pediatric clinical care.
SUBMITTER: Pereira S
PROVIDER: S-EPMC9992280 | biostudies-literature | 2023 Mar
REPOSITORIES: biostudies-literature
Pereira Stacey S Gutierrez Amanda M AM Robinson Jill Oliver JO Christensen Kurt D KD Genetti Casie A CA Blout Zawatsky Carrie L CL Hsu Rebecca L RL Zettler Bethany B Uveges Melissa Kurtz MK Parad Richard B RB Beggs Alan H AH Holm Ingrid A IA Green Robert C RC McGuire Amy L AL
Genetics in medicine : official journal of the American College of Medical Genetics 20221220 3
<h4>Purpose</h4>Most professional guidelines recommend against genetic screening for adult-onset only (AO) conditions until adulthood, yet others argue that there may be benefit to disclosing such results. We explored parents' decision-making on this issue in the BabySeq Project, a clinical trial of newborn genomic sequencing.<h4>Methods</h4>We conducted interviews with parents (N = 24) who were given the option to receive actionable AO results for their children. Interviews explored parents' mo ...[more]